1,455 Followers on Owler

Fedora Pharma

Read more
Christopher G. Micetich's photo - President & CEO of Fedora Pharma

President & CEO

Christopher G. Micetich

CEO Approval Rating

73/100

Founded:

2012

Status:

PrivateIndependent Company

Est. Annual Revenue
$3.6M
Agree?
Est. Employees
74
Agree?

FEDORA PHARMA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Fedora Pharma's company profile
Christopher G. Micetich's photo - President & CEO of Fedora Pharma

Christopher G. Micetich

President & CEO

73/100
74
$200.1K
$3.6M
View Profile
1
Fedora Pharma's Competitor - Nosopharm logo
Philippe Villain-Guillot's photo - Co-Founder & CEO of Nosopharm

Philippe Villain-Guillot

Co-Founder & CEO

74/100
10
$5M
$5M
View Profile
2
Fedora Pharma's Competitor - Merck logo
Robert M. Davis's photo - CEO of Merck

Robert M. Davis

CEO

84/100
69,000
- -
$50.1B
View Profile
3
Fedora Pharma's Competitor - AstraZeneca logo
Pascal Soriot's photo - CEO of AstraZeneca

Pascal Soriot

CEO

80/100
76,100
- -
$29.5B
View Profile
4
Fedora Pharma's Competitor - Rempex Pharmaceuticals logo
Daniel D. Burgess's photo - President & CEO of Rempex Pharmaceuticals

Daniel D. Burgess

President & CEO

70/100
62
$67.5M
$18M
View Profile
5
Fedora Pharma's Competitor - VenatoRx logo
Christopher J. Burns's photo - President & CEO of VenatoRx

Christopher J. Burns

President & CEO

73/100
36
$30.5M
$3M
View Profile
6
Fedora Pharma's Competitor - Digital First Media logo
CEO Avatar

CEO

- -
610
- -
$75.1M
View Profile
7
Fedora Pharma's Competitor - Pfizer logo
Albert Bourla's photo - Chairman & CEO of Pfizer

Albert Bourla

Chairman & CEO

76/100
92,400
- -
$55.5B
View Profile
8
Fedora Pharma's Competitor - Novartis logo
Vasant Narasimhan's photo - CEO of Novartis

Vasant Narasimhan

CEO

87/100
110,000
- -
$50.4B
View Profile
9
Fedora Pharma's Competitor - Amgen logo
Robert A. Bradway's photo - Chairman & CEO of Amgen

Robert A. Bradway

Chairman & CEO

66/100
24,300
$4.1B
$26.7B
View Profile
10
Fedora Pharma's Competitor - GSK logo
Dame Emma Walmsley's photo - CEO of GSK

Dame Emma Walmsley

CEO

74/100
94,066
- -
$45.5B
View Profile
11
Fedora Pharma's Competitor - BMS logo
Giovanni Caforio's photo - Chairman & CEO of BMS

Giovanni Caforio

Chairman & CEO

65/100
23,300
- -
$44.4B
View Profile
12
Fedora Pharma's Competitor - Johnson & Johnson logo
Alex Gorsky's photo - Chairman & CEO of Johnson & Johnson

Alex Gorsky

Chairman & CEO

82/100
135,100
- -
$89.2B
View Profile

Missing a competitor? Contribute!

Nosopharm is seen as one of Fedora Pharma's top competitors. Nosopharm was founded in Lyon Cedex, Rhône Alpes} in 2009. Nosopharm is in the Pharmaceuticals industry. Compared to Fedora Pharma, Nosopharm generates $1.4M more revenue.

Merck is Fedora Pharma's #2 competitor. Merck was founded in 1891, and its headquarters is in Kenilworth, New Jersey. Merck competes in the Pharmaceuticals industry. Merck has 73,926 more employees than Fedora Pharma.

AstraZeneca is Fedora Pharma's #3 rival. AstraZeneca is headquartered in Cambridge, England, and was founded in 1999. Like Fedora Pharma, AstraZeneca also competes in the Pharmaceuticals industry. AstraZeneca generates 821,497% the revenue of Fedora Pharma.

Fedora Pharma Acquisitions

No recent acquisitions found related to Fedora Pharma

Fedora Pharma Funding History

Since Fedora Pharma was founded in 2012, it has participated in 1 round of funding. In total Fedora Pharma has raised $200.1K. Fedora Pharma's funding round was on Apr 2013 for a total of $200.1K

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Apr 2013
$200.1K
-

Since Fedora Pharma was founded in 2012, it has participated in 1 round of funding. In total Fedora Pharma has raised $200.1K. Fedora Pharma's funding round was on Apr 2013 for a total of $200.1K

Fedora Pharma Investments

No recent investments found related to Fedora Pharma

Fedora Pharma News

January 14, 2015CENTER WATCH

Roche, Meiji and Fedora partner to explore bacterial resistance to antibiotics

Roche, Meiji Seika Pharma and Fedora have entered into a license agreement for the development and co... See more »
January 13, 2015BUSINESS RECORDER

Roche signs antibiotics licence deal to fight superbugs

ZURICH: Swiss pharmaceutical giant Roche said Tuesday it would pay up to $750 million for rights to a... See more »
January 13, 2015BIOPORTFOLIO

Roche inks $750M antibiotic pact with Meiji and Fedora

Roche inks $750M antibiotic pact with Meiji and Fedora... See more »

Fedora Pharma Blogs

February 10, 2016Fedora Pharma Blog

Super drugs for superbugs: Edmonton firm wins largest biotech licensing deal in Canadian history

Doctors around the world are starting to speak with one voice with regards to superbugs, those ever-e... See more »
January 5, 2016Fedora Pharma Blog

Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance

Antimicrobials, and specifically antibiotics, play a crucial role in modern medicine. These precious ... See more »
November 30, 2015Fedora Pharma Blog

Fedora Pharmaceuticals Receives Alberta Life Sciences "Company of the Year" Award

Fedora Pharmaceuticals Receives Alberta Life Sciences "Company of the Year" Award EDMONTON, Alberta –... See more »
November 9, 2015Fedora Pharma Blog

Fedora Pharmaceuticals Inc. Receives 2015 ASTech Award for Outstanding Commercial Achievement

EDMONTON, Alberta – November 9, 2015 – Fedora Pharmaceuticals Inc., a biotechnology company headquart... See more »
January 13, 2015Fedora Pharma Blog

Roche, Meiji and Fedora join forces to tackle increasing bacterial resistance to antibiotics

 Roche licenses investigational beta-lactamase inhibitor OP0595 OP0595 targets beta-lactamase enzym... See more »

Fedora Pharma Press Releases

Social Media

Fedora Pharma Headquarters

11629 – 105 Avenue

Edmonton, AlbertaAB T5H 0L9

780-757-5401

Driving Directions »

Trending Companies

Fedora Pharma Summary

ABOUT

Overview

Fedora Pharma discovers and develops antibiotic products for life-threatening microbial drug resistance. Fedora Pharma was founded in 2012. Fedora Pharma's headquarters is located in Edmonton, Alberta, CA AB T5H 0L9. It has raised 200.1K in 1 round. T...

CEO

Fedora Pharma's President & CEO, Christopher G. Micetich, currently has an approval rating of 73%. Fedora Pharma's primary competitors are Nosopharm, Merck & AstraZeneca.

Frequently Asked Questions about Fedora Pharma

  1. When was Fedora Pharma founded?

    Fedora Pharma was founded in 2012
  2. Who is Fedora Pharma's CEO?

    Fedora Pharma's CEO is Christopher G. Micetich
  3. How much revenue does Fedora Pharma generate?

    Fedora Pharma generates $3.6M in revenue
  4. How much funding does Fedora Pharma have?

    Fedora Pharma has historically raised $200.1K in funding
  1. Where is Fedora Pharma's headquarters?

    Fedora Pharma's headquarters is in Edmonton Alberta, CA
  2. How many employees does Fedora Pharma have?

    Fedora Pharma has 74 employees
  3. What sector does Fedora Pharma operate in?

    Fedora Pharma is in Pharmaceuticals
  4. Who are Fedora Pharma's competitors?

    Fedora Pharma's top competitors are Nosopharm, Merck, AstraZeneca